Drug Trial Radar · NCT04325776
A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis
Last checked: Nov 19, 2026Latest source record: Oct 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
60
Planned (sponsor's estimate)
Start
Sep 24, 2020
Primary completion
May 2021
Study completion Nov 2021
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 30, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
AL2846 is a multi-target tyrosine kinase receptor inhibitor with obvious selective to c-met, suggesting that its anti-tumor effect mainly inhibits the activation of key downstream oncogenic pathways by inhibiting expression of c-met, tumor angiogenesis and tumor cell migration.
Conditions
- Bone Metastatic Non-small Cell Lung Cancer
Interventions
AL2846Drug
AL2846 is a multi-target tyrosine kinase receptor inhibitor with obvious selective to c-met.
Zoledronic Acid InjectionDrug
Zoledronic acid is a bisphosphonate drug that has a strong inhibition of bone resorption and a potential to promote bone formation, and can be used for bone metastasis caused by malignant tumors.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The time when the first bone-related event (SRE) occurredTime frame: up to 96 weeks
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Anhui Chest Hospital
Hefei, Anhui, China · Recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
China-Japan Union Hospital Of Jilin University
Changchun, Jilin, China · Not yet recruiting
Jinzhou Central Hospital
Jinzhou, Liaoning, China · Recruiting
Shenyang Chest Hospital
Shenyang, Liaoning, China · Recruiting
Sir Run Run Shaw Hospital (SRRSH)
Hangzhou, Zhejiang, China · Recruiting
The First Hospital of Jiaxing
Jiaxing, Zhejiang, China · Not yet recruiting
Quzhou People's Hospital
Quzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.